BSE filing, NSE: BHAGCHEM. Summary written from the filing by ALFA Finder's alert engine.
Bhagiradha Chemicals & Industries Ltd: key numbers
- Share price
- ₹205.63
- Market cap
- ₹2,666 Cr
- Revenue (annual)
- ₹535.9 Cr
- Net profit (annual)
- ₹18.17 Cr
- P/E (TTM)
- 96.9×Sector 34.5×
- Promoter holding
- 19.60%+0.00% QoQ
- FII holding
- 0.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bhagiradha Chemicals & Industries Ltd
All →Bhagiradha Chemicals & Industries Other Announcement
Bhagiradha Chemicals & Industries Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Bhagiradha Chemicals & Industries Credit Rating
India Ratings assigned a credit rating of IND BBB+/Stable/IND A2+ to bank loan facilities of Bhagiradha Chemicals' subsidiary, Bheema Fine Chemicals.
Bhagiradha Chemicals & Industries Investor Presentation: Key Takeaways
Q1FY27 recorded highest-ever quarterly performance with ₹195 Cr revenue. Strategy shifts toward high-margin molecules and scaling the new Bheema facility.
- Call
- Guides 250% growth
Bhagiradha Chemicals & Industries Q1 FY27 Results: Net Profit ₹13.3 Cr, Up 232.5% YoY
Bhagiradha Chemicals & Industries Ltd reported revenue from operations of ₹195 Cr (+57.5% YoY) and net profit of ₹13.3 Cr (+232.5% YoY) for Q1 FY27.
- Key figure
- Net profit ₹13.3 Cr · +232.5% YoY
Bhagiradha Chemicals & Industries Annual General Meeting
Bhagiradha Chemicals and Industries Limited conducted its 33rd Annual General Meeting on July 31, 2026. Shareholders approved all resolutions, including a final dividend of ₹0.15 per equity share.
Bhagiradha Chemicals & Industries Board Meeting Date
Bhagiradha Chemicals scheduled a Board Meeting for August 3, 2026. The board will consider the unaudited financial results for the quarter ended June 30, 2026.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.